Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Jacomen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Endoscopy|August 8, 2025
Prototype of a novel cold snare polypectomy deviceLode Van Overbeke, Gerd Jacomen, Koen Chiers
Gynecologic Oncology Reports|September 14, 2019
Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol Oncol 2019;152:202-7Cecile Colpaert, Gerd Jacomen, Koen Van de Vijver, et al.
Gynecologic Oncology|June 24, 2005
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancerFrederic Amant, Isabelle Cadron, Luca Fuso, et al.
Gynecologic Oncology|December 12, 2023
Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT databaseJoren Vanbraband, Nancy Van Damme, Geert Silversmit, et al.
BMC Cancer|June 1, 2022
Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT)Joren Vanbraband, Nancy Van Damme, Gauthier Bouche, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 27, 2025
Increased hospital case volume is associated with improved survival and quality of care for uterine corpus cancer in BelgiumJoren Vanbraband, Nancy Van Damme, Geert Silversmit, et al.
European Urology|April 26, 2024
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment PersonalizationLaura Elst, Gino Philips, Kaat Vandermaesen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Endoscopy|August 8, 2025
Prototype of a novel cold snare polypectomy deviceLode Van Overbeke, Gerd Jacomen, Koen Chiers
Gynecologic Oncology Reports|September 14, 2019
Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol Oncol 2019;152:202-7Cecile Colpaert, Gerd Jacomen, Koen Van de Vijver, et al.
Gynecologic Oncology|June 24, 2005
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancerFrederic Amant, Isabelle Cadron, Luca Fuso, et al.
Gynecologic Oncology|December 12, 2023
Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT databaseJoren Vanbraband, Nancy Van Damme, Geert Silversmit, et al.
BMC Cancer|June 1, 2022
Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT)Joren Vanbraband, Nancy Van Damme, Gauthier Bouche, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 27, 2025
Increased hospital case volume is associated with improved survival and quality of care for uterine corpus cancer in BelgiumJoren Vanbraband, Nancy Van Damme, Geert Silversmit, et al.
European Urology|April 26, 2024
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment PersonalizationLaura Elst, Gino Philips, Kaat Vandermaesen, et al.
Pageof 1